Market Tracker

09/17 6:02pm ET

Dynavax Technologies Corp (NASDAQ:DVAX)

1.34
Data as of Sep 17
 -0.01 / -0.74%
Today’s Change
1.10
Today|||52-Week Range
2.14
-31.63%
Year-to-Date
No recent news for Dynavax Technologies Corp.

Today’s Trading

Previous close1.35
Today’s open1.34
Day’s range1.32 - 1.38
Volume502,911
Average volume (3 months)1,715,797
Market cap$354.9M
Dividend yield--
Data as of 3:59pm ET, 09/17/2014

Growth & Valuation

Earnings growth (last year)+7.32%
Earnings growth (this year)+11.05%
Earnings growth (next 5 years)--
Revenue growth (last year)+15.82%
P/E ratioNM
Price/Sales34.19
Price/Book1.90

Competitors

 Today’s
change
Today’s
% change
SUPNSupernus Pharmaceuti...+0.18+2.18%
NWBONorthwest Biotherape...-0.16-2.73%
PGNXProgenics Pharmaceut...+0.12+2.31%
SCLNSciClone Pharmaceuti...-0.14-1.95%
Data as of 4:14pm ET, 09/17/2014

Financials

Next reporting dateOctober 30, 2014
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$11.3M
Annual profit (last year)-$66.7M
Net profit margin-593.01%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Eddie J. Gray
Senior Vice President-Operations &
Quality
David F. Novack
Corporate headquarters
Berkeley, California

Forecasts